PSY33 Adaptation to Colombia and Venezuela of the Economic Model Dasatinib First-Line Treatment of Chronic Myeloid Leukemia, Developed by the York Health Economics Consortium

J.J Orozco,J.E Valencia

doi:10.1016/j.jval.2012.03.567

PSY33 Adaptation to Colombia and Venezuela of the Economic Model Dasatinib First-Line Treatment of Chronic Myeloid Leukemia, Developed by the York Health Economics Consortium

J.J Orozco, J.E Valencia

Open Access

https://doi.org/10.1016/j.jval.2012.03.567

Copy DOI

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research	Publication Date: May 23, 2012
License type: publisher-specific-oa

#York Health Economics Consortium #Treatment Of Chronic Myeloid Leukemia + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

PSY33 Adaptation to Colombia and Venezuela of the Economic Model Dasatinib First-Line Treatment of Chronic Myeloid Leukemia, Developed by the York Health Economics Consortium

Full Text